(2S,5R)-5-HYDROXYPIPERIDINE-2-CARBOXYLIC ACID HCL, 97.0%, 100mg

(+)-Pulegone>85.0%(GC)25mL

Oxyde d'hydroxyde de fer(III), minimum 85 % Fe2O3, technique, 100 g, emballage plastique.

TERT-BUTYL 3-HYDROXY-3-PHENYLAZETIDINE-1-CARBOXYLATE, 95.0%, 5g

METHYL 1-(4-METHOXYBENZYL)-5-OXOPYRROLIDINE-3-CARBOXYLATE, 95.0%, 100mg

2-(2-(2-morpholinothiazol-4-yl)ethyl)isoindoline-1,3-dione hydrochloride, 95.0%, 250mg

ENTACAPONE, 95%, 25g

n-[(2,4-dimethoxyphenyl)methyl]-3-iodo-1h-pyrazolo[4,3-c]pyridin-4-amine, 98%, 1g

[2,5'-BIPYRIMIDINE]-5-CARBONITRILE, 95.0%, 250mg

(1Z,2Z)-Cyclohexane-1,2-dione dioxime, 97.0%, 25g

4-Bromo-2-fluorobenzoyl chloride, 95.0%, 25g

1,4-Bis(acryloyl)piperazine>98.0%(GC)1g

Hexanoyl Chloride>98.0%(GC)(T)500g